Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the ankylosing spondylitis market right now?

Over the past few years, the market size for ankylosing spondylitis has seen robust growth. It is predicted to rise from $5.9 billion in 2024 to $6.36 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. Several factors have spurred growth in the historical period, including the discovery of HLA-B27, the development of biologic treatments, advancements in pain management strategies, increased patient advocacy and awareness, the use of NSAIDS, and disease-modifying drugs.

How fast Is the ankylosing spondylitis market expected to grow, and what’s its future value?

In the coming years, the market size of ankylosing spondylitis is predicted to experience significant growth, anticipated to reach $8.71 billion by 2029 with a compound annual growth rate (CAGR) of 8.2%. This growth during the predicted timeframe can be credited to factors like the approach of personalized medicine, the evolution of novel biologics, early involvement and screenings, management of lifestyle and diet, as well as telemedicine and remote patient monitoring. The future market trends are expected to focus on the availability of biosimilars, targeted therapies for pain management, importance of patient-reported outcomes (pros), community-oriented support programs, and exploring regenerative medicine.

Get your ankylosing spondylitis market report here!

https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

What are the leading drivers of growth in the ankylosing spondylitis market?

The rise in the elderly population is predicted to fuel the expansion of the ankylosing spondylitis market in future. The term “geriatric population” denotes an upsurge in the count of senior citizens driven by alterations in a population’s age composition. This demographic transition has escalated the quantity and percentage of individuals over 60 years old. Medications and treatments for ankylosing spondylitis assist in enhancing mobility and controlling pain among seniors afflicted with the condition. For example, in January 2023, the United Nations Department of Economic and Social Affairs (UN DESA), a division of the UN Secretariat located in the US, projected that the worldwide count of those aged 65 and over would more than double, rising from 761 million in 2021 to 1.6 billion by 2050. Consequently, the swelling geriatric population is pushing the ankylosing spondylitis market’s growth.

What are the key segments defining the ankylosing spondylitis market?

The ankylosing spondylitis market covered in this report is segmented –

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery

2) By Molecule: Biologics, Biosimilar, Small Molecules

3) By Route Of Administration: Parenteral, Oral, Other Routes

4) By Application: Juveniles, Adults

5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users

Subsegments:

1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs, Prescription NSAIDs

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted DMARDs

3) By Biological Therapies: TNF Inhibitors, IL-17 Inhibitors

4) By Steroids: Oral Steroids, Injectable Steroids

5) By Physical Therapies: Physiotherapy, Exercise Programs

6) By Surgery: Joint Replacement Surgery, Spinal Surgery

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

Who are the key players steering the development of the ankylosing spondylitis market?

Major companies operating in the ankylosing spondylitis market include Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.

What emerging trends are influencing the growth of the ankylosing spondylitis market?

The focus on the development of new therapeutic options is becoming a prevalent trend in the ankylosing spondylitis market. Ankylosing spondylitis enterprises are introducing innovative therapeutic options to maintain their market dominance. A prime example took place in April 2022 when US biopharmaceutical firm AbbVie Inc. received U.S. Food and Drug Administration (FDA) approval for RINVOQ, a medication designed for the treatment of adults suffering from active ankylosing spondylitis (AS). This opens up a new oral treatment pathway for patients who haven’t had success with TNF blockers, demonstrated by substantial improvements in disease symptoms like back pain and physical functioning. The swift effectiveness and safety profile exhibited in clinical trials position it as an important step forward in managing this chronic inflammatory disease, broadening the range of therapeutic options accessible to patients.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11962

Which regions are most influential in expanding the ankylosing spondylitis market?

North America was the largest region in the ankylosing spondylitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Luxury Hair Care Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/luxury-hair-care-products-global-market-report

Retail And Wholesale Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/retail-and-wholesale-global-market-report

Personal Care Ingredients Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/personal-care-ingredients-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: